Related Experiment Videos
A neuroimmune interaction in painful peripheral neuropathy
1Department of Neurology, MCP Hahnemann University, Philadelphia, Pennsylvania 19102-1192, USA. Gary.Bennett@drexel.edu
The Clinical Journal of Pain
|October 3, 2000
Summary
Inflammation significantly contributes to neuropathic pain following nerve damage. Immune-modulating drugs, like cyclosporin-A, show promise in treating these pain states.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Background:
- Neuropathic pain often involves both structural nerve damage and inflammation.
- The precise role of the inflammatory response, independent of structural lesions, in neuropathic pain requires further elucidation.
Purpose of the Study:
- To isolate and quantify the contribution of the inflammatory response to neuropathic pain.
- To investigate the efficacy of immune-modulating agents in mitigating neuropathic pain.
Main Methods:
- Induced experimental neuritis (nerve inflammation) and myositis (muscle inflammation) in rats.
- Assessed pain responses including heat hyperalgesia, mechanical allodynia, mechanical hyperalgesia, and cold allodynia.
- Administered thalidomide and cyclosporin-A to modulate immune responses in neuritis and chronic constriction injury models.
Main Results:
- Neuritis induced neuropathic pain symptoms, while myositis did not.
- Thalidomide partially reduced pain in the chronic constriction injury model but not in the neuritis model.
- Cyclosporin-A demonstrated a dose-related reduction in pain across both models.
Conclusions:
- Evidence suggests a significant interaction between the immune and nervous systems in neuropathic pain.
- Immune-modulating therapies may offer a viable treatment strategy for specific neuropathic pain conditions.